Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

2',3'-isopropylideneguanosine

Known as: IPG cpd 
 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

2',3'-isopropylideneguanosine hemihydrate

Broader (1)

Guanosine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Clinical outcomes of VNS therapy with AspireSR® (including cardiac-based seizure detection) at a large complex epilepsy and surgery centre
PURPOSE To compare the efficacy of AspireSR® to preceding VNS battery models for battery replacements, and to determine the… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2016
Highly Cited
2016
Highly transparent and flexible supercapacitors using graphene-graphene quantum dots chelate
Abstract Nowadays, transparent and flexible energy storage devices are attracting a great deal of research interest due to their… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Morphology Diagram of a Diblock Copolymer−Aluminosilicate Nanoparticle System
We explore the morphology space of nanocomposites prepared from poly(isoprene-block-ethylene oxide) (PI-b-PEO) diblock copolymers… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2009
2009
Stability of symptom control after replacement of impulse generators for deep brain stimulation.
OBJECT Impulse generators (IPGs) for deep brain stimulation (DBS) need to be replaced when their internal batteries fail or when… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome.
Some actions of insulin are mediated by inositolphosphoglycan (IPG) mediators. Deficient release of a putative D-chiro-inositol… Expand
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.
UNLABELLED BACKGROUND We have shown that American women with polycystic ovary syndrome (PCOS) have decreased glucose-stimulated… Expand
  • table I
  • figure 1
  • table II
  • table III
Is this relevant?
2007
2007
Urinary excretion of inositol phosphoglycan P‐type in gestational diabetes mellitus
Objective  The mechanisms underlying insulin resistance during normal pregnancy, and its further exacerbation in pregnancies… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome.
OBJECTIVE Evidence suggests that some actions of insulin are effected by inositolphosphoglycan (IPG) mediators. We hypothesize… Expand
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2.
CONTEXT Preeclampsia is a severe complication of human pregnancy often associated with maternal risk factors. Insulin resistance… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome.
Some actions of insulin are mediated by putative inositolphosphoglycan mediators, and a deficiency in D-chiro-inositol-containing… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE